Pontifax Management III G.P. (2011) Ltd. 13D/13G Filings for Eloxx Pharmaceuticals, Inc. (ELOX)

Pontifax Management III G.P. (2011) Ltd. 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-05-21
4:05 pm
Purchase
2021-05-1813DEloxx Pharmaceuticals, Inc.
ELOX
Pontifax Management III G.P. (2011) Ltd.186,520
8.660%
6,816increase
(+3.79%)
Filing